» Articles » PMID: 28381299

Emerging Concepts in Liquid Biopsies

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2017 Apr 7
PMID 28381299
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

Characterizing and monitoring tumor genomes with blood samples could achieve significant improvements in precision medicine. As tumors shed parts of themselves into the circulation, analyses of circulating tumor cells, circulating tumor DNA, and tumor-derived exosomes, often referred to as "liquid biopsies", may enable tumor genome characterization by minimally invasive means. Indeed, multiple studies have described how molecular information about parent tumors can be extracted from these components. Here, we briefly summarize current technologies and then elaborate on emerging novel concepts that may further propel the field. We address normal and detectable mutation levels in the context of our current knowledge regarding the gradual accumulation of mutations during aging and in light of technological limitations. Finally, we discuss whether liquid biopsies are ready to be used in routine clinical practice.

Citing Articles

An early lung cancer diagnosis model for non-smokers incorporating ct imaging analysis and circulating genetically abnormal cells (CACs).

Ni R, Huang Y, Wang L, Chen H, Zhang G, Yu Y BMC Cancer. 2025; 25(1):124.

PMID: 39844169 PMC: 11756104. DOI: 10.1186/s12885-024-13268-5.


Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of Glioma.

Lu Y, Wang Z, Zhang D, Luo N, Yang H, Chen D Cell Mol Neurobiol. 2024; 45(1):6.

PMID: 39692767 PMC: 11655607. DOI: 10.1007/s10571-024-01515-z.


Roles and Applications of Circulating Tumor-Derived RNAs in Sarcoma Patients: A Systematic Review.

Gabrielli E, Bocchi M, Giuli C, Farine F, Costa D, Maccauro G Int J Mol Sci. 2024; 25(21).

PMID: 39519267 PMC: 11546317. DOI: 10.3390/ijms252111715.


Advances and challenges in the use of liquid biopsy in gynaecological oncology.

Zhang Y, Tian L Heliyon. 2024; 10(20):e39148.

PMID: 39492906 PMC: 11530831. DOI: 10.1016/j.heliyon.2024.e39148.


Exosomes isolation from bovine serum: qualitative and quantitative comparison between ultracentrifugation, combination ultracentrifugation and size exclusion chromatography, and exoEasy methods.

Bok E, Seo S, Lee H, Wimalasena S, Kim E, Cho A J Anim Sci Technol. 2024; 66(5):1021-1033.

PMID: 39398302 PMC: 11466739. DOI: 10.5187/jast.2024.e45.


References
1.
Miyamoto D, Zheng Y, Wittner B, Lee R, Zhu H, Broderick K . RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science. 2015; 349(6254):1351-6. PMC: 4872391. DOI: 10.1126/science.aab0917. View

2.
Alsop K, Thorne H, Sandhu S, Hamilton A, Mintoff C, Christie E . A community-based model of rapid autopsy in end-stage cancer patients. Nat Biotechnol. 2016; 34(10):1010-1014. DOI: 10.1038/nbt.3674. View

3.
Heitzer E, Auer M, Gasch C, Pichler M, Ulz P, Hoffmann E . Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res. 2013; 73(10):2965-75. DOI: 10.1158/0008-5472.CAN-12-4140. View

4.
Mohan S, Heitzer E, Ulz P, Lafer I, Lax S, Auer M . Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing. PLoS Genet. 2014; 10(3):e1004271. PMC: 3967949. DOI: 10.1371/journal.pgen.1004271. View

5.
Heitzer E, Ulz P, Belic J, Gutschi S, Quehenberger F, Fischereder K . Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing. Genome Med. 2013; 5(4):30. PMC: 3707016. DOI: 10.1186/gm434. View